Gail Bukofzer
Impact in
- Microbiology top 5%
- Bacterial Infections and Vaccines
-
- PARP inhibition in cancer therapy
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Oncology 10
- Chemokine receptors and signaling 2
- CAR-T cell therapy research 2
-
- Signaling Pathways in Disease 2
- Cancer therapeutics and mechanisms 2
- Co-authors
- Michael J. Mitten (1 shared paper)Jessica L. VonCannon (1 shared paper)W. Edward Swords (1 shared paper)Cherrie K. Donawho (9 shared papers)Joann P. Palma (5 shared papers)Luis E. Rodrı́guez (4 shared papers)T. H. Bothwell (5 shared papers)Saul H. Rosenberg (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)American Journal of Hematology (3 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)Molecular Imaging and Biology (1 paper)
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
Gail Bukofzer
17 papers receiving 389 citations
Peers
Comparison fields: 5 of 69
- Microbiology 85
- Oncology 166
- Genetics 37
- Otorhinolaryngology 13
- Molecular Biology 185
Countries citing papers authored by Gail Bukofzer
This map shows the geographic impact of Gail Bukofzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Bukofzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Bukofzer more than expected).
Fields of papers citing papers by Gail Bukofzer
This network shows the impact of papers produced by Gail Bukofzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Bukofzer. The network helps show where Gail Bukofzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Gail Bukofzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 115 | |
| 2 | 2009 | 111 | |
| 3 | 2008 | 42 | |
| 4 | 2008 | 25 | |
| 5 | 2019 | 20 | |
| 6 | Transferrin receptors and transferrin iron uptake by cultured human blood monocytes. | 1987 | 20 |
| 7 | 2011 | 17 | |
| 8 | 2017 | 11 | |
| 9 | 2023 | 7 | |
| 10 | 1987 | 7 | |
| 11 | Transferrin iron interactions with cultured hepatocellular carcinoma cells (PLC/PRF/5). | 1988 | 6 |
| 12 | 1988 | 5 | |
| 13 | 1989 | 5 | |
| 14 | The RTK inhibitor ABT-869, alone and in combination with paclitaxel and/or zoledronic acid, demonstrates significant reduction in the development of both osteoblastic (LuCap 23.1) and osteolytic (PC3-M-Luciferase) tumors intratibially | 2007 | 2 |
| 15 | The RTK inhibitor, ABT-869 alone or in combination with various cytotoxic therapies demonstrate significant tumor growth inhibition in orthotopic hepatocellular carcinoma, renal cell carcinoma and prostate xenografts | 2007 | 1 |
| 16 | 2012 | 1 | |
| 17 | 2018 | 1 |
About Gail Bukofzer
Gail Bukofzer is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Hematology and Immunology, having authored 17 papers that have together received 396 indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers), Hemoglobinopathies and Related Disorders (2 papers), Signaling Pathways in Disease (2 papers), Cancer therapeutics and mechanisms (2 papers), Chemokine receptors and signaling (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Microbiology (85 citations), Oncology (166 citations), Genetics (37 citations), Otorhinolaryngology (13 citations) and Molecular Biology (185 citations). Gail Bukofzer has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Michael J. Mitten, Jessica L. VonCannon, W. Edward Swords, Cherrie K. Donawho, Joann P. Palma, Luis E. Rodrı́guez, T. H. Bothwell, Saul H. Rosenberg, Vincent L. Giranda and Xuesong Liu. Their work appears in journals such as Molecular Cancer Therapeutics, American Journal of Hematology, Cancer Research, Clinical Cancer Research and Molecular Imaging and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.